香港股市周二早盘上涨130点,涨幅0.5%,至25264点,连续第四个交易日上涨,同时保持2021年11月以来的最高水平。在特朗普总统宣布与日本达成涉及15%关税的贸易协议后,美国期货价格显著上涨,所有板块均上涨。与此同时,受西藏1700亿美元水电项目的启动、美中贸易紧张局势的缓解以及北京对机械、汽车和电气设备等关键行业的新政策支持的推动,内地市场也创下3年半以来的新高。投资者也在本月晚些时候中国即将召开的政治局会议之前做好了准备,预计该会议将影响今年剩余时间的经济政策。Genscript Biotech在预测今年上半年将恢复盈利后,股价飙升5.8%。其他涨幅最大的股票包括中信有限公司(2.5%)、创新生物(2.3%)、太创工业(2.1%)和腾讯控股(1.6%)。
Hong Kong shares rose 130 points or 0.5% to 25,264 on Tuesday morning deals, extending gains for the fourth straight session while staying at their highest level since November 2021. All sectors advanced, supported by a notable rise in U.S. futures after President Trump announced a trade deal with Japan involving a 15% tariff. Meanwhile, mainland markets also notched to a 3-1/2-year high, driven by the launch of a $170 billion hydropower project in Tibet, easing U.S.-China trade tensions, and fresh policy support from Beijing for key sectors including machinery, autos, and electrical equipment. Investors also positioned ahead of China’s upcoming Politburo meeting later this month, which is expected to shape economic policy for the remainder of the year. Genscript Biotech surged 5.8% after forecasting a return to profit in the first half of the year. Other top gainers included Citic Ltd. (2.5%), Innovent Biologics (2.3%), Techtronic Industries (2.1%), and Tencent Holdings (1.6%).